Natus Medical (BABY) Tops Q1 EPS by 2c; Boosts FY15 Outlook

Natus Medical (NASDAQ: BABY) reported Q1 EPS of $0.31, $0.02 better than the analyst estimate of $0.29. Revenue for the quarter came in at $89.4 million versus the consensus estimate of $88.93 million.

Natus Medical sees Q2 2015 EPS of $0.31-$0.33, versus the consensus of $0.32. Natus Medical sees Q2 2015 revenue of $89.5-91.5 million, versus the consensus of $90.4 million.

Natus Medical sees FY2015 EPS of $1.47-$1.51, versus prior guidance of $1.42-$1.46 and the consensus of $1.45. Natus Medical sees FY2015 revenue of $376-378 million, versus prior guidance of $373-375 million and the consensus of $374.6 million.

For earnings history and earnings-related data on Natus Medical (BABY) click here.

You May Also Be Interested In

• MFA Financial (MFA) Misses Q3 EPS by 2c
• Harmony Biosciences (HRMY) Misses Q3 EPS by 30c; Offers Guidance
• SharkNinja (SN) Tops Q3 EPS by 74c; Offers Guidance